{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T06:39:33Z","timestamp":1792823973721,"version":"4.5.0"},"reference-count":198,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82027807"],"award-info":[{"award-number":["82027807"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019018","name":"Chinese Academy of Medical Sciences Initiative for Innovative Medicine","doi-asserted-by":"publisher","award":["2019-I2M-5-056"],"award-info":[{"award-number":["2019-I2M-5-056"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["L252007"],"award-info":[{"award-number":["L252007"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017610","name":"Shenzhen Science and Technology Innovation Program","doi-asserted-by":"publisher","award":["AI2026013"],"award-info":[{"award-number":["AI2026013"]}],"id":[{"id":"10.13039\/501100017610","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004147","name":"Tsinghua University","doi-asserted-by":"publisher","award":["2022TS014"],"award-info":[{"award-number":["2022TS014"]}],"id":[{"id":"10.13039\/501100004147","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004147","name":"Tsinghua University","doi-asserted-by":"publisher","award":["10001020123"],"award-info":[{"award-number":["10001020123"]}],"id":[{"id":"10.13039\/501100004147","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2025YFF0523800"],"award-info":[{"award-number":["2025YFF0523800"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.canlet.2026.218881","type":"journal-article","created":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:02:10Z","timestamp":1791356530000},"page":"218881","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Deciphering the metastatic nexus: Molecular drivers and therapeutic frontiers in cholangiocarcinoma lymph node dissemination"],"prefix":"10.1016","volume":"661","author":[{"given":"Ming-Yu","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-Yuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Fei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin-Lin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Zhen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Hao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang-Yu","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-Qiao","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Liang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Hong","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2026.218881_bib1","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jhep.2019.03.013","article-title":"Global trends in mortality from intrahepatic and extrahepatic cholangiocarcinoma","volume":"71","author":"Bertuccio","year":"2019","journal-title":"J. Hepatol."},{"key":"10.1016\/j.canlet.2026.218881_bib2","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","article-title":"Cholangiocarcinoma 2020: the next horizon in mechanisms and management","volume":"17","author":"Banales","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.canlet.2026.218881_bib3","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1053\/j.gastro.2011.12.005","article-title":"Genomic and genetic characterization of cholangiocarcinoma identifies therapeutic targets for tyrosine kinase inhibitors","volume":"142","author":"Andersen","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.canlet.2026.218881_bib4","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/SLA.0000000000003801","article-title":"Meta-analysis and meta-regression of survival after liver transplantation for unresectable perihilar cholangiocarcinoma","volume":"273","author":"Cambridge","year":"2021","journal-title":"Ann. Surg."},{"key":"10.1016\/j.canlet.2026.218881_bib5","doi-asserted-by":"crossref","DOI":"10.1097\/SLA.0000000000006773","article-title":"Recommendations on perihilar cholangiocarcinoma. The milan jury-based consensus","author":"Pfister","year":"2025","journal-title":"Ann. Surg."},{"key":"10.1016\/j.canlet.2026.218881_bib6","first-page":"93","volume":"vol. 67","author":"Amin","year":"2017"},{"key":"10.1016\/j.canlet.2026.218881_bib7","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1038\/s41467-022-29164-0","article-title":"Single-cell transcriptomic analysis suggests two molecularly subtypes of intrahepatic cholangiocarcinoma","volume":"13","author":"Song","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2026.218881_bib8","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1186\/s12967-024-05238-z","article-title":"Integrative analyses of bulk and single-cell transcriptomics reveals the infiltration and crosstalk of cancer-associated fibroblasts as a novel predictor for prognosis and microenvironment remodeling in intrahepatic cholangiocarcinoma","volume":"22","author":"Zhong","year":"2024","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.canlet.2026.218881_bib9","doi-asserted-by":"crossref","first-page":"627","DOI":"10.3390\/cells10030627","article-title":"Progression of metastasis through lymphatic system","volume":"10","author":"Zhou","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.canlet.2026.218881_bib10","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/nrd4608","article-title":"From sewer to saviour - targeting the lymphatic system to promote drug exposure and activity","volume":"14","author":"Trevaskis","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.canlet.2026.218881_bib11","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.cell.2016.11.037","article-title":"Emerging biological principles of metastasis","volume":"168","author":"Lambert","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2026.218881_bib12","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3389\/fonc.2011.00042","article-title":"Prediction of the lymph node status in patients with intrahepatic cholangiocarcinoma: analysis of 320 surgical cases","volume":"1","author":"Chen","year":"2011","journal-title":"Front. Oncol."},{"key":"10.1016\/j.canlet.2026.218881_bib13","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1186\/s12885-024-12068-1","article-title":"Development and validation of a novel preoperative clinical model for predicting lymph node metastasis in perihilar cholangiocarcinoma","volume":"24","author":"Mao","year":"2024","journal-title":"BMC Cancer"},{"key":"10.1016\/j.canlet.2026.218881_bib14","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1245\/s10434-008-0236-0","article-title":"Immunohistochemically detected expression of p27(Kip1) and Skp2 predicts survival in patients with intrahepatic cholangiocarcinomas","volume":"16","author":"Hashimoto","year":"2009","journal-title":"Ann. Surg Oncol."},{"key":"10.1016\/j.canlet.2026.218881_bib15","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1038\/s41419-018-1087-7","article-title":"BAP1 acts as a tumor suppressor in intrahepatic cholangiocarcinoma by modulating the ERK1\/2 and JNK\/c-Jun pathways","volume":"9","author":"Chen","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2026.218881_bib16","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1016\/j.ejca.2012.12.015","article-title":"Aberrant expression of GATA binding protein 6 correlates with poor prognosis and promotes metastasis in cholangiocarcinoma","volume":"49","author":"Tian","year":"2013","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.canlet.2026.218881_bib17","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1002\/hep.20718","article-title":"Genome-wide analysis of gene expression in human intrahepatic cholangiocarcinoma","volume":"41","author":"Obama","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.canlet.2026.218881_bib18","doi-asserted-by":"crossref","first-page":"829","DOI":"10.2353\/ajpath.2009.080012","article-title":"Cyclooxygenase-2 is involved in the up-regulation of matrix metalloproteinase-9 in cholangiocarcinoma induced by tumor necrosis factor-alpha","volume":"174","author":"Itatsu","year":"2009","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.canlet.2026.218881_bib19","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.jhep.2019.11.021","article-title":"MUC13 promotes intrahepatic cholangiocarcinoma progression via EGFR\/PI3K\/AKT pathways","volume":"72","author":"Tiemin","year":"2020","journal-title":"J. Hepatol."},{"key":"10.1016\/j.canlet.2026.218881_bib20","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.apsb.2015.07.005","article-title":"Cancer metastases: challenges and opportunities","volume":"5","author":"Guan","year":"2015","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.canlet.2026.218881_bib21","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s40659-015-0016-9","article-title":"TGF-\u03b21 expression is associated with invasion and metastasis of intrahepatic cholangiocarcinoma","volume":"48","author":"Chen","year":"2015","journal-title":"Biol. Res."},{"key":"10.1016\/j.canlet.2026.218881_bib22","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.3760\/cma.j.issn.0366-6999.20121235","article-title":"Inactivation of Smad4 is a prognostic factor in intrahepatic cholangiocarcinoma","volume":"126","author":"Yan","year":"2013","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.canlet.2026.218881_bib23","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1038\/s41419-017-0015-6","article-title":"Upregulation of B7-H4 promotes tumor progression of intrahepatic cholangiocarcinoma","volume":"8","author":"Xie","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2026.218881_bib24","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1002\/hep.28149","article-title":"Mitogen-activated protein kinase kinase kinase 4 deficiency in intrahepatic cholangiocarcinoma leads to invasive growth and epithelial-mesenchymal transition","volume":"62","author":"Yang","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.canlet.2026.218881_bib25","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1038\/s41388-023-02651-4","article-title":"Serine\/threonine kinase TBK1 promotes cholangiocarcinoma progression via direct regulation of \u03b2-catenin","volume":"42","author":"Gao","year":"2023","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2026.218881_bib26","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.dld.2018.08.021","article-title":"MicroRNA-494-dependent WDHDI inhibition suppresses epithelial-mesenchymal transition, tumor growth and metastasis in cholangiocarcinoma","volume":"51","author":"Liu","year":"2019","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.canlet.2026.218881_bib27","doi-asserted-by":"crossref","first-page":"4048","DOI":"10.1093\/nar\/gkq1338","article-title":"WDHD1 modulates the post-transcriptional step of the centromeric silencing pathway","volume":"39","author":"Hsieh","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.canlet.2026.218881_bib28","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.jhep.2018.12.004","article-title":"Platelet-derived growth factor-D enables liver myofibroblasts to promote tumor lymphangiogenesis in cholangiocarcinoma","volume":"70","author":"Cadamuro","year":"2019","journal-title":"J. Hepatol."},{"key":"10.1016\/j.canlet.2026.218881_bib29","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/j.jhep.2021.07.016","article-title":"Thrombospondin 1 and 2 along with PEDF inhibit angiogenesis and promote lymphangiogenesis in intrahepatic cholangiocarcinoma","volume":"75","author":"Carpino","year":"2021","journal-title":"J. Hepatol."},{"key":"10.1016\/j.canlet.2026.218881_bib30","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/ajg.2009.674","article-title":"Tumor-associated angiogenesis and lymphangiogenesis correlate with progression of intrahepatic cholangiocarcinoma","volume":"105","author":"Thelen","year":"2010","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.canlet.2026.218881_bib31","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1245\/s10434-007-9774-0","article-title":"Tumor-associated lymphangiogenesis correlates with lymph node metastases and prognosis in hilar cholangiocarcinoma","volume":"15","author":"Thelen","year":"2008","journal-title":"Ann. Surg Oncol."},{"key":"10.1016\/j.canlet.2026.218881_bib32","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.cardiores.2004.12.002","article-title":"The biology of vascular endothelial growth factors","volume":"65","author":"Tammela","year":"2005","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.canlet.2026.218881_bib33","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.7150\/ijbs.26045","article-title":"Expression of VEGFR-3 in intrahepatic cholangiocarcinoma correlates with unfavorable prognosis through lymphangiogenesis","volume":"14","author":"Sha","year":"2018","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.canlet.2026.218881_bib34","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1007\/s00535-023-02012-8","article-title":"Dual FGFR and VEGFR inhibition synergistically restrain hexokinase 2-dependent lymphangiogenesis and immune escape in intrahepatic cholangiocarcinoma","volume":"58","author":"Peng","year":"2023","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.canlet.2026.218881_bib35","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1002\/cncr.27788","article-title":"High expression of Dickkopf-related protein 1 is related to lymphatic metastasis and indicates poor prognosis in intrahepatic cholangiocarcinoma patients after surgery","volume":"119","author":"Shi","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.canlet.2026.218881_bib36","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/modpathol.3800985","article-title":"Lymphatic spread is related to VEGF-C expression and D2-40-positive myofibroblasts in intrahepatic cholangiocarcinoma","volume":"21","author":"Aishima","year":"2008","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.canlet.2026.218881_bib37","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.jhep.2016.09.010","article-title":"Epithelial-mesenchymal transition in cholangiocarcinoma: from clinical evidence to regulatory networks","volume":"66","author":"Vaquero","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.canlet.2026.218881_bib38","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1002\/hep.24588","article-title":"Myofibroblast-derived PDGF-BB promotes Hedgehog survival signaling in cholangiocarcinoma cells","volume":"54","author":"Fingas","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.canlet.2026.218881_bib39","doi-asserted-by":"crossref","first-page":"369","DOI":"10.14336\/AD.2023.0420","article-title":"Cancer-associated fibroblasts promote lymphatic metastasis in cholangiocarcinoma via the PDGF-BB\/PDGFR-\u03b2 mediated paracrine signaling network","volume":"15","author":"Yan","year":"2024","journal-title":"Aging Dis"},{"key":"10.1016\/j.canlet.2026.218881_bib40","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1002\/hep.26384","article-title":"Platelet-derived growth factor-D and rho GTPases regulate recruitment of cancer-associated fibroblasts in cholangiocarcinoma","volume":"58","author":"Cadamuro","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.canlet.2026.218881_bib41","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.hpb.2021.11.008","article-title":"Targeted amplicon sequencing for primary tumors and matched lymph node metastases in patients with extrahepatic cholangiocarcinoma","volume":"24","author":"Yamada","year":"2022","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.canlet.2026.218881_bib42","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-28941-6","article-title":"ACGH detects distinct genomic alterations of primary intrahepatic cholangiocarcinomas and matched lymph node metastases and identifies a poor prognosis subclass","volume":"8","author":"Jansen","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2026.218881_bib43","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ccell.2021.12.006","article-title":"Proteogenomic characterization identifies clinically relevant subgroups of intrahepatic cholangiocarcinoma","volume":"40","author":"Dong","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2026.218881_bib44","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature13441","article-title":"Mutant IDH inhibits HNF-4\u03b1 to block hepatocyte differentiation and promote biliary cancer","volume":"513","author":"Saha","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2026.218881_bib45","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1038\/s41388-023-02661-2","article-title":"KIF14 promotes proliferation, lymphatic metastasis and chemoresistance through G3BP1\/YBX1 mediated NF-\u03baB pathway in cholangiocarcinoma","volume":"42","author":"Jiang","year":"2023","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2026.218881_bib46","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.bcp.2019.05.017","article-title":"UCP2 regulates cholangiocarcinoma cell plasticity via mitochondria-to-AMPK signals","volume":"166","author":"Yu","year":"2019","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.canlet.2026.218881_bib47","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nrc3262","article-title":"Deconvoluting the context-dependent role for autophagy in cancer","volume":"12","author":"White","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2026.218881_bib48","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.4161\/auto.7.10.16610","article-title":"Prognostic significance of beclin 1 in intrahepatic cholangiocellular carcinoma","volume":"7","author":"Dong","year":"2011","journal-title":"Autophagy"},{"key":"10.1016\/j.canlet.2026.218881_bib49","article-title":"Beclin 1 deficiency correlated with lymph node metastasis, predicts a distinct outcome in intrahepatic and extrahepatic cholangiocarcinoma","volume":"8","author":"Wang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.canlet.2026.218881_bib50","doi-asserted-by":"crossref","first-page":"395","DOI":"10.4161\/auto.6.3.11303","article-title":"Elevated beclin 1 expression is correlated with HIF-1alpha in predicting poor prognosis of nasopharyngeal carcinoma","volume":"6","author":"Wan","year":"2010","journal-title":"Autophagy"},{"key":"10.1016\/j.canlet.2026.218881_bib51","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1158\/2159-8290.CD-17-0952","article-title":"Autophagy sustains pancreatic cancer growth through both cell-autonomous and nonautonomous mechanisms","volume":"8","author":"Yang","year":"2018","journal-title":"Cancer Discov."},{"key":"10.1016\/j.canlet.2026.218881_bib52","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/HEP.0000000000000784","article-title":"Oleic acid-PPAR\u03b3-FABP4 loop fuels cholangiocarcinoma colonization in lymph node metastases microenvironment","volume":"80","author":"Zhang","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.canlet.2026.218881_bib53","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/s41568-020-00320-2","article-title":"The metabolism of cancer cells during metastasis","volume":"21","author":"Bergers","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2026.218881_bib54","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","article-title":"The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth","volume":"41","author":"de Visser","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2026.218881_bib55","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cell.2010.03.014","article-title":"Macrophage diversity enhances tumor progression and metastasis","volume":"141","author":"Qian","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2026.218881_bib56","doi-asserted-by":"crossref","DOI":"10.1126\/science.aax4063","article-title":"Biological functions of lymphatic vessels","volume":"369","author":"Petrova","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.canlet.2026.218881_bib57","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.cell.2015.08.016","article-title":"Metabolic competition in the tumor microenvironment is a driver of cancer progression","volume":"162","author":"Chang","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2026.218881_bib58","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.ccell.2021.03.012","article-title":"Promotion of cholangiocarcinoma growth by diverse cancer-associated fibroblast subpopulations","volume":"39","author":"Affo","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2026.218881_bib59","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2026.218881_bib60","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/s41571-023-00770-1","article-title":"Cholangiocarcinoma - novel biological insights and therapeutic strategies","volume":"20","author":"Ilyas","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.canlet.2026.218881_bib61","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.jhep.2023.05.010","article-title":"Immunobiology of cholangiocarcinoma","volume":"79","author":"Tomlinson","year":"2023","journal-title":"J. Hepatol."},{"key":"10.1016\/j.canlet.2026.218881_bib62","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.canlet.2015.07.039","article-title":"Tumor microenvironment: sanctuary of the devil","volume":"368","author":"Hui","year":"2015","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2026.218881_bib63","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1097\/HEP.0000000000001423","article-title":"Tumor microenvironment heterogeneity and progression mechanisms in intrahepatic cholangiocarcinoma: a study based on single-cell and spatial transcriptomic sequencing","volume":"83","author":"Li","year":"2026","journal-title":"Hepatology"},{"key":"10.1016\/j.canlet.2026.218881_bib64","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1038\/bjc.2013.610","article-title":"Prognostic impact of tumour-infiltrating immune cells on biliary tract cancer","volume":"109","author":"Goeppert","year":"2013","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canlet.2026.218881_bib65","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.radonc.2015.07.003","article-title":"High ratio of programmed cell death protein 1 (PD-1)(+)\/CD8(+) tumor-infiltrating lymphocytes identifies a poor prognostic subset of extrahepatic bile duct cancer undergoing surgery plus adjuvant chemoradiotherapy","volume":"117","author":"Lim","year":"2015","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.canlet.2026.218881_bib66","doi-asserted-by":"crossref","first-page":"851","DOI":"10.3390\/cells12060851","article-title":"Expression of checkpoint molecules in the tumor microenvironment of intrahepatic cholangiocarcinoma: implications for immune checkpoint blockade therapy","volume":"12","author":"Heij","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.canlet.2026.218881_bib67","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/cac2.12513","article-title":"Multiomics analysis reveals metabolic subtypes and identifies diacylglycerol kinase \u03b1 (DGKA) as a potential therapeutic target for intrahepatic cholangiocarcinoma","volume":"44","author":"Liu","year":"2024","journal-title":"Cancer Commun."},{"key":"10.1016\/j.canlet.2026.218881_bib68","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.jhep.2020.05.039","article-title":"Single-cell transcriptomic architecture and intercellular crosstalk of human intrahepatic cholangiocarcinoma","volume":"73","author":"Zhang","year":"2020","journal-title":"J. Hepatol."},{"key":"10.1016\/j.canlet.2026.218881_bib69","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/s41379-020-00702-9","article-title":"Prognostic impact of tumor microvessels in intrahepatic cholangiocarcinoma: association with tumor-infiltrating lymphocytes","volume":"34","author":"Yugawa","year":"2021","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.canlet.2026.218881_bib70","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13046-021-02235-8","article-title":"Macrophages-aPKC\u0269-CCL5 feedback loop modulates the progression and chemoresistance in cholangiocarcinoma","volume":"41","author":"Yang","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2026.218881_bib71","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.semcancer.2012.03.004","article-title":"What are regulatory T cells (Treg) regulating in cancer and why?","volume":"22","author":"Whiteside","year":"2012","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.canlet.2026.218881_bib72","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1245\/s10434-012-2268-8","article-title":"Intratumoral IL-17+ cells and neutrophils show strong prognostic significance in intrahepatic cholangiocarcinoma","volume":"19","author":"Gu","year":"2012","journal-title":"Ann. Surg Oncol."},{"key":"10.1016\/j.canlet.2026.218881_bib73","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1002\/hep.29296","article-title":"aPKC-\u03b9\/P-Sp1\/Snail signaling induces epithelial-mesenchymal transition and immunosuppression in cholangiocarcinoma","volume":"66","author":"Qian","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.canlet.2026.218881_bib74","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/s41416-021-01569-6","article-title":"Cancer-associated fibroblast senescence and its relation with tumour-infiltrating lymphocytes and PD-L1 expressions in intrahepatic cholangiocarcinoma","volume":"126","author":"Lan","year":"2022","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canlet.2026.218881_bib75","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/s41392-024-01761-z","article-title":"Alpha5 nicotine acetylcholine receptor subunit promotes intrahepatic cholangiocarcinoma metastasis","volume":"9","author":"Fu","year":"2024","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.canlet.2026.218881_bib76","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1007\/s00268-010-0417-4","article-title":"Nerve growth factor-beta expression is associated with lymph node metastasis and nerve infiltration in human hilar cholangiocarcinoma","volume":"34","author":"Xu","year":"2010","journal-title":"World J. Surg."},{"key":"10.1016\/j.canlet.2026.218881_bib77","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1038\/s41416-022-01933-0","article-title":"Spatiotemporal analysis of tumour-infiltrating immune cells in biliary carcinogenesis","volume":"127","author":"Charbel","year":"2022","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canlet.2026.218881_bib78","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s40364-024-00648-z","article-title":"Spatial resolved transcriptomics reveals distinct cross-talk between cancer cells and tumor-associated macrophages in intrahepatic cholangiocarcinoma","volume":"12","author":"Dong","year":"2024","journal-title":"Biomark. Res."},{"key":"10.1016\/j.canlet.2026.218881_bib79","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/cncr.34552","article-title":"The clinicopathological significance and relapse predictive role of tumor microenvironment of intrahepatic cholangiocarcinoma after radical surgery","volume":"129","author":"Zheng","year":"2023","journal-title":"Cancer"},{"key":"10.1016\/j.canlet.2026.218881_bib80","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1245\/s10434-016-5101-y","article-title":"Program death 1 immune checkpoint and tumor microenvironment: implications for patients with intrahepatic cholangiocarcinoma","volume":"23","author":"Gani","year":"2016","journal-title":"Ann. Surg Oncol."},{"key":"10.1016\/j.canlet.2026.218881_bib81","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.jhep.2021.10.030","article-title":"Distribution and density of tertiary lymphoid structures predict clinical outcome in intrahepatic cholangiocarcinoma","volume":"76","author":"Ding","year":"2022","journal-title":"J. Hepatol."},{"key":"10.1016\/j.canlet.2026.218881_bib82","doi-asserted-by":"crossref","DOI":"10.1172\/JCI155478","article-title":"Lymphangiogenesis requires Ang2\/Tie\/PI3K signaling for VEGFR3 cell-surface expression","volume":"132","author":"Korhonen","year":"2022","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.canlet.2026.218881_bib83","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.surg.2016.03.020","article-title":"The favorable prognosis after operative resection of hypervascular intrahepatic cholangiocarcinoma: a clinicopathologic and immunohistochemical study","volume":"160","author":"T\u00fcrko\u011flu","year":"2016","journal-title":"Surgery"},{"key":"10.1016\/j.canlet.2026.218881_bib84","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1053\/j.gastro.2023.11.302","article-title":"Fibroblast-derived lysyl oxidase increases oxidative phosphorylation and stemness in cholangiocarcinoma","volume":"166","author":"Lewinska","year":"2024","journal-title":"Gastroenterology"},{"key":"10.1016\/j.canlet.2026.218881_bib85","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.cell.2012.04.042","article-title":"A CXCL1 paracrine network links cancer chemoresistance and metastasis","volume":"150","author":"Acharyya","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2026.218881_bib86","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.3390\/cells10113093","article-title":"Tumor lymphatic interactions induce CXCR2-CXCL5 axis and alter cellular metabolism and lymphangiogenic pathways to promote cholangiocarcinoma","volume":"10","author":"Roy","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.canlet.2026.218881_bib87","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1097\/HEP.0000000000000206","article-title":"Heterogeneity, crosstalk, and targeting of cancer-associated fibroblasts in cholangiocarcinoma","volume":"79","author":"Cantallops Vil\u00e0","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.canlet.2026.218881_bib88","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.2353\/ajpath.2006.050204","article-title":"Possible regulation of migration of intrahepatic cholangiocarcinoma cells by interaction of CXCR4 expressed in carcinoma cells with tumor necrosis factor-alpha and stromal-derived factor-1 released in stroma","volume":"168","author":"Ohira","year":"2006","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.canlet.2026.218881_bib89","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s13046-014-0103-8","article-title":"Blockade of CXCL12\/CXCR4 signaling inhibits intrahepatic cholangiocarcinoma progression and metastasis via inactivation of canonical wnt pathway","volume":"33","author":"Zhao","year":"2014","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2026.218881_bib90","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/nri.2017.142","article-title":"NF-\u03baB, inflammation, immunity and cancer: coming of age","volume":"18","author":"Taniguchi","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.canlet.2026.218881_bib91","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.cmet.2016.08.011","article-title":"LDHA-associated lactic acid production blunts tumor immunosurveillance by T and NK cells","volume":"24","author":"Brand","year":"2016","journal-title":"Cell Metab."},{"key":"10.1016\/j.canlet.2026.218881_bib92","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ccell.2022.01.008","article-title":"Dangerous dynamic duo: lactic acid and PD-1 blockade","volume":"40","author":"Johnson","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2026.218881_bib93","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.636568","article-title":"Cancer immune evasion through loss of MHC class I antigen presentation","volume":"12","author":"Dhatchinamoorthy","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2026.218881_bib94","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1158\/1078-0432.CCR-18-3200","article-title":"Biological consequences of MHC-II expression by tumor cells in cancer","volume":"25","author":"Axelrod","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2026.218881_bib95","doi-asserted-by":"crossref","first-page":"5380","DOI":"10.1172\/JCI137110","article-title":"Targeting tumor-associated macrophages and granulocytic myeloid-derived suppressor cells augments PD-1 blockade in cholangiocarcinoma","volume":"130","author":"Loeuillard","year":"2020","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.canlet.2026.218881_bib96","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.ccell.2017.10.005","article-title":"Cancer-associated fibroblasts neutralize the anti-tumor effect of CSF1 receptor blockade by inducing PMN-MDSC infiltration of tumors","volume":"32","author":"Kumar","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2026.218881_bib97","doi-asserted-by":"crossref","first-page":"e1187","DOI":"10.1097\/SLA.0000000000003788","article-title":"Number and station of lymph node metastasis after curative-intent resection of intrahepatic cholangiocarcinoma impact prognosis","volume":"274","author":"Zhang","year":"2021","journal-title":"Ann. Surg."},{"key":"10.1016\/j.canlet.2026.218881_bib98","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/s43018-020-0043-5","article-title":"Circulating tumor DNA and liquid biopsy in oncology","volume":"1","author":"Cescon","year":"2020","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.canlet.2026.218881_bib99","doi-asserted-by":"crossref","DOI":"10.1038\/srep16103","article-title":"Circulating miR-106a is a novel prognostic and lymph node metastasis indicator for cholangiocarcinoma","volume":"5","author":"Cheng","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2026.218881_bib100","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1478-3231.2004.00886.x","article-title":"Decreased expression of osteopontin is related to tumor aggressiveness and clinical outcome of intrahepatic cholangiocarcinoma","volume":"24","author":"Terashi","year":"2004","journal-title":"Liver Int."},{"key":"10.1016\/j.canlet.2026.218881_bib101","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.jhep.2021.06.028","article-title":"Single-cell atlas of tumor cell evolution in response to therapy in hepatocellular carcinoma and intrahepatic cholangiocarcinoma","volume":"75","author":"Ma","year":"2021","journal-title":"J. Hepatol."},{"key":"10.1016\/j.canlet.2026.218881_bib102","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13045-019-0772-z","article-title":"Tumor-derived exosomes, myeloid-derived suppressor cells, and tumor microenvironment","volume":"12","author":"Tian","year":"2019","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.canlet.2026.218881_bib103","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1016\/j.cmet.2021.09.002","article-title":"Tumor-derived exosomes drive immunosuppressive macrophages in a pre-metastatic niche through glycolytic dominant metabolic reprogramming","volume":"33","author":"Morrissey","year":"2021","journal-title":"Cell Metab."},{"key":"10.1016\/j.canlet.2026.218881_bib104","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/s12951-024-02459-8","article-title":"Circulating tumor cell-derived exosome-transmitted long non-coding RNA TTN-AS1 can promote the proliferation and migration of cholangiocarcinoma cells","volume":"22","author":"Zhou","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.canlet.2026.218881_bib105","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s12885-021-07838-0","article-title":"LncRNA MT1JP plays a protective role in intrahepatic cholangiocarcinoma by regulating miR-18a-5p\/FBP1 axis","volume":"21","author":"Zhao","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.canlet.2026.218881_bib107","article-title":"Integrin \u03b26 serves as an immunohistochemical marker for lymph node metastasis and promotes cell invasiveness in cholangiocarcinoma","volume":"6","author":"Li","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2026.218881_bib164","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.57","article-title":"Dicer promotes tumorigenesis by translocating to nucleus to promote SFRP1 promoter methylation in cholangiocarcinoma cells","volume":"8","author":"Cheng","year":"2017","journal-title":"Cell Death Dis."},{"issue":"Suppl 3","key":"10.1016\/j.canlet.2026.218881_bib165","doi-asserted-by":"crossref","first-page":"S667","DOI":"10.1245\/s10434-013-3135-y","article-title":"Enhancer of zeste homolog 2 (EZH2) promotes progression of cholangiocarcinoma cells by regulating cell cycle and apoptosis","volume":"20","author":"Nakagawa","year":"2013","journal-title":"Ann. Surg Oncol."},{"key":"10.1016\/j.canlet.2026.218881_bib169","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2020.108367","article-title":"MiR-19b-3p facilitates the proliferation and epithelial-mesenchymal transition, and inhibits the apoptosis of intrahepatic cholangiocarcinoma by suppressing coiled-coil domain containing 6","volume":"686","author":"Tang","year":"2020","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.canlet.2026.218881_bib184","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.dld.2014.03.017","article-title":"67 laminin receptor promotes the malignant potential of tumour cells up-regulating lysyl oxidase-like 2 expression in cholangiocarcinoma","volume":"46","author":"Xu","year":"2014","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.canlet.2026.218881_bib185","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3390\/biom9090413","article-title":"Serum apurinic\/apyrimidinic endodeoxyribonuclease 1 (APEX1) level as a potential biomarker of cholangiocarcinoma","volume":"9","author":"Tummanatsakun","year":"2019","journal-title":"Biomolecules"},{"key":"10.1016\/j.canlet.2026.218881_bib186","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1097\/PAS.0b013e31820ffdf1","article-title":"Different roles of S100P overexpression in intrahepatic cholangiocarcinoma: carcinogenesis of perihilar type and aggressive behavior of peripheral type","volume":"35","author":"Aishima","year":"2011","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.canlet.2026.218881_bib187","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.3390\/biom10071021","article-title":"Apoptosis-inducing factor, mitochondrion-associated 3 (AIFM3) protein level in the sera as a prognostic marker of cholangiocarcinoma patients","volume":"10","author":"Chua-On","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.canlet.2026.218881_bib188","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.biopha.2018.08.011","article-title":"TPX2 level correlates with cholangiocarcinoma cell proliferation, apoptosis, and EMT","volume":"107","author":"Zou","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.canlet.2026.218881_bib189","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.705378","article-title":"CTLA-4 synergizes with PD1\/PD-L1 in the inhibitory tumor microenvironment of intrahepatic cholangiocarcinoma","volume":"12","author":"Guo","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2026.218881_bib117","doi-asserted-by":"crossref","first-page":"70378","DOI":"10.18632\/oncotarget.11859","article-title":"Dickkopf-1 expression is associated with tumorigenity and lymphatic metastasis in human hilar cholangiocarcinoma","volume":"7","author":"Shi","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2026.218881_bib163","doi-asserted-by":"crossref","first-page":"196","DOI":"10.5009\/gnl.2014.8.2.196","article-title":"Silencing of CXCR4 inhibits tumor cell proliferation and neural invasion in human hilar cholangiocarcinoma","volume":"8","author":"Tan","year":"2014","journal-title":"Gut Liver"},{"key":"10.1016\/j.canlet.2026.218881_bib106","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2022.836985","article-title":"Serum angiopoietin-like protein 4: a potential prognostic biomarker for prediction of vascular invasion and lymph node metastasis in cholangiocarcinoma patients","volume":"10","author":"Aung","year":"2022","journal-title":"Front. Public Health"},{"key":"10.1016\/j.canlet.2026.218881_bib190","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1046\/j.1365-2559.2002.00353.x","article-title":"c-erbB-2 and c-Met expression relates to cholangiocarcinogenesis and progression of intrahepatic cholangiocarcinoma","volume":"40","author":"Aishima","year":"2002","journal-title":"Histopathology"},{"key":"10.1016\/j.canlet.2026.218881_bib191","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112403","article-title":"Inositol 1,4,5-trisphosphate receptor type 3 (ITPR3) is overexpressed in cholangiocarcinoma and its expression correlates with S100 calcium-binding protein A4 (S100A4)","volume":"145","author":"Rodrigues","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.canlet.2026.218881_bib192","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.172915","article-title":"Calcium-sensing receptor promotes tumor proliferation and migration in human intrahepatic cholangiocarcinoma by targeting ERK signaling pathway","volume":"872","author":"Fang","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.canlet.2026.218881_bib193","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.canlet.2013.05.003","article-title":"Expression of cytoskeleton-associated protein 4 is related to lymphatic metastasis and indicates prognosis of intrahepatic cholangiocarcinoma patients after surgery resection","volume":"337","author":"Li","year":"2013","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2026.218881_bib194","doi-asserted-by":"crossref","first-page":"3839","DOI":"10.1111\/febs.13894","article-title":"TLR2 promotes human intrahepatic cholangiocarcinoma cell migration and invasion by modulating NF-\u03baB pathway-mediated inflammatory responses","volume":"283","author":"Liu","year":"2016","journal-title":"FEBS J."},{"key":"10.1016\/j.canlet.2026.218881_bib162","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/jso.25192","article-title":"CD90 expression in human intrahepatic cholangiocarcinoma is associated with lymph node metastasis and poor prognosis","volume":"118","author":"Yamaoka","year":"2018","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/j.canlet.2026.218881_bib195","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1097\/01.MP.0000086860.65672.73","article-title":"Tenascin expression at the invasive front is associated with poor prognosis in intrahepatic cholangiocarcinoma","volume":"16","author":"Aishima","year":"2003","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.canlet.2026.218881_bib196","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1002\/cncr.10398","article-title":"Correlation between expression of MUC1 core protein and outcome after surgery in mass-forming intrahepatic cholangiocarcinoma","volume":"94","author":"Matsumura","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.canlet.2026.218881_bib170","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1159\/000354531","article-title":"miR-204 inhibits epithelial to mesenchymal transition by targeting slug in intrahepatic cholangiocarcinoma cells","volume":"32","author":"Qiu","year":"2013","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.canlet.2026.218881_bib171","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1002\/mc.23262","article-title":"miR-885-5p inhibits proliferation and metastasis by targeting IGF2BP1 and GALNT3 in human intrahepatic cholangiocarcinoma","volume":"59","author":"Lixin","year":"2020","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.canlet.2026.218881_bib172","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s10528-021-10084-5","article-title":"miR-181b-5p promotes the progression of cholangiocarcinoma by targeting PARK2 via PTEN\/PI3K\/AKT signaling pathway","volume":"60","author":"Jiang","year":"2022","journal-title":"Biochem. Genet."},{"key":"10.1016\/j.canlet.2026.218881_bib174","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/s41419-022-05412-5","article-title":"JUND\/linc00976 promotes cholangiocarcinoma progression and metastasis, inhibits ferroptosis by regulating the miR-3202\/GPX4 axis","volume":"13","author":"Lei","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2026.218881_bib175","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1007\/s10620-021-06876-9","article-title":"Long non-coding RNA FOXD2-AS1 promotes proliferation, migration, and invasion in cholangiocarcinoma through regulating miR-760\/E2F3 axis","volume":"67","author":"Hu","year":"2022","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.canlet.2026.218881_bib166","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1093\/abbs\/gmaa117","article-title":"COUP-TFII promotes metastasis and epithelial-to-mesenchymal transition through upregulating snail in human intrahepatic cholangiocarcinoma","volume":"52","author":"Lang","year":"2020","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"10.1016\/j.canlet.2026.218881_bib197","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2025.102290","article-title":"HNF4\u03b1 inhibits the malignancy of intrahepatic cholangiocarcinoma by suppressing the Wnt signaling pathway","volume":"53","author":"Xu","year":"2025","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.canlet.2026.218881_bib115","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/s41416-022-01838-y","article-title":"Regulatory T cells induce a suppressive immune milieu and promote lymph node metastasis in intrahepatic cholangiocarcinoma","volume":"127","author":"Konishi","year":"2022","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canlet.2026.218881_bib167","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1111\/cas.12249","article-title":"Forkhead box protein C2 contributes to invasion and metastasis of extrahepatic cholangiocarcinoma, resulting in a poor prognosis","volume":"104","author":"Watanabe","year":"2013","journal-title":"Cancer Sci."},{"key":"10.1016\/j.canlet.2026.218881_bib179","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s00535-024-02090-2","article-title":"Characterization of tumor microbiome and associations with prognosis in intrahepatic cholangiocarcinoma","volume":"59","author":"Xin","year":"2024","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.canlet.2026.218881_bib198","doi-asserted-by":"crossref","DOI":"10.1111\/jgh.14124","article-title":"Impact of serum carbohydrate antigen 19-9 level on prognosis and prediction of lymph node metastasis in patients with intrahepatic cholangiocarcinoma","author":"Yamada","year":"2018","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.canlet.2026.218881_bib108","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2020.153022","article-title":"Integrin \u03b1v\u03b26 predicts poor prognosis and promotes resistance to cisplatin in hilar cholangiocarcinoma","volume":"216","author":"Sun","year":"2020","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.canlet.2026.218881_bib109","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1080\/14737159.2023.2205588","article-title":"Clinicopathological, etiological and molecular characteristics of intrahepatic cholangiocarcinoma subtypes classified by mucin production and immunohistochemical features","volume":"23","author":"Chen","year":"2023","journal-title":"Expert Rev. Mol. Diagn"},{"key":"10.1016\/j.canlet.2026.218881_bib110","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/j.ejso.2015.05.013","article-title":"Intrahepatic, peri-hilar and distal cholangiocarcinoma: three different locations of the same tumor or three different tumors?","volume":"41","author":"Ercolani","year":"2015","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.canlet.2026.218881_bib111","doi-asserted-by":"crossref","DOI":"10.1097\/HEP.0000000000001672","article-title":"Anatomic subsets of cholangiocarcinoma: more different than alike","author":"Dong","year":"2026","journal-title":"Hepatology"},{"key":"10.1016\/j.canlet.2026.218881_bib112","doi-asserted-by":"crossref","DOI":"10.1111\/his.70157","article-title":"Understanding cholangiocarcinoma: molecular landscape, pathological classification, and challenges in biopsy diagnosis","author":"Zen","year":"2026","journal-title":"Histopathology"},{"key":"10.1016\/j.canlet.2026.218881_bib113","doi-asserted-by":"crossref","first-page":"7163","DOI":"10.1245\/s10434-025-17811-x","article-title":"Blurring the anatomical lines in extrahepatic cholangiocarcinoma: an integrated clinic-oncological and exploratory proteomic comparison of perihilar and distal tumors","volume":"32","author":"Marichez","year":"2025","journal-title":"Ann. Surg Oncol."},{"key":"10.1016\/j.canlet.2026.218881_bib114","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/s41420-024-02079-z","article-title":"Mobilization and activation of tumor-infiltrating dendritic cells inhibits lymph node metastasis in intrahepatic cholangiocarcinoma","volume":"10","author":"Sun","year":"2024","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.canlet.2026.218881_bib116","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0081347","article-title":"Down-regulation of Gab1 inhibits cell proliferation and migration in hilar cholangiocarcinoma","volume":"8","author":"Sang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.canlet.2026.218881_bib118","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s13045-025-01716-z","article-title":"Deciphering cholangiocarcinoma heterogeneity and specific progenitor cell niche of extrahepatic cholangiocarcinoma at single-cell resolution","volume":"18","author":"Liu","year":"2025","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.canlet.2026.218881_bib119","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-05645-2","article-title":"Activated cancer-associated fibroblasts correlate with poor survival and decreased lymphocyte infiltration in infiltrative type distal cholangiocarcinoma","volume":"15","author":"Lim","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2026.218881_bib120","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","article-title":"Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer","volume":"362","author":"Valle","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2026.218881_bib121","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.jhep.2025.05.003","article-title":"Durvalumab plus chemotherapy in advanced biliary tract cancer: 3-year overall survival update from the phase III TOPAZ-1 study","volume":"83","author":"Oh","year":"2025","journal-title":"J. Hepatol."},{"key":"10.1016\/j.canlet.2026.218881_bib122","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1016\/S0140-6736(23)00727-4","article-title":"Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"401","author":"Kelley","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.canlet.2026.218881_bib123","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.1158\/1078-0432.CCR-24-0517","article-title":"FDA approval summary: Durvalumab and pembrolizumab, immune checkpoint inhibitors for the treatment of biliary tract cancer","volume":"30","author":"Casak","year":"2024","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2026.218881_bib124","article-title":"Tislelizumab combined with donafenib and GEMOX as first-line treatment for advanced biliary tract cancer: a single-arm, phase II study","volume":"44","author":"Zhao","year":"2026","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2026.218881_bib125","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1056\/NEJMoa2513918","article-title":"Neoadjuvant GOLP in resectable high-risk intrahepatic cholangiocarcinoma","volume":"394","author":"Shi","year":"2026","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2026.218881_bib126","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001240","article-title":"Camrelizumab plus gemcitabine and oxaliplatin (GEMOX) in patients with advanced biliary tract cancer: a single-arm, open-label, phase II trial","volume":"8","author":"Chen","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.canlet.2026.218881_bib127","article-title":"A phase 2 randomized, open-label, multicentre study of sintilimab and anlotinib in combination with gemcitabine plus cisplatin (GemCis) as first-line therapy in patients (pts) with advanced biliary tract cancer (BTC): SAGC","volume":"41","author":"Jingjing","year":"2023","journal-title":"J. Clin. Orthod."},{"key":"10.1016\/j.canlet.2026.218881_bib128","article-title":"Case report: camrelizumab combined with gemcitabine and oxaliplatin in the treatment of advanced intrahepatic cholangiocarcinoma: a case report and literature review","volume":"14","author":"Zhang","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2026.218881_bib129","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/s41392-023-01317-7","article-title":"Toripalimab combined with lenvatinib and GEMOX is a promising regimen as first-line treatment for advanced intrahepatic cholangiocarcinoma: a single-center, single-arm, phase 2 study","volume":"8","author":"Shi","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.canlet.2026.218881_bib130","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/S2468-1253(24)00095-5","article-title":"Durvalumab or placebo plus gemcitabine and cisplatin in participants with advanced biliary tract cancer (TOPAZ-1): updated overall survival from a randomised phase 3 study","volume":"9","author":"Oh","year":"2024","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.canlet.2026.218881_bib131","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2026.44.16_suppl.4118","article-title":"Envafolimab (KN035) plus gemcitabine and oxaliplatin (GEMOX) compared with GEMOX as first-line treatment for Chinese patients with advanced biliary tract cancer: a randomized, open-label, multi-center, phase III pivotal trial","volume":"44","author":"Qin","year":"2026","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2026.218881_bib132","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2026.6849","article-title":"First-line chemotherapy regimens for unresectable locally advanced or metastatic biliary tract cancer: a systematic review and bayesian network meta-analysis","volume":"9","author":"Elemosho","year":"2026","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.canlet.2026.218881_bib133","first-page":"CLO26","article-title":"CLO26-112: durvalumab versus pembrolizumab with gemcitabine and cisplatin in first-line treatment of advanced biliary tract cancer: a real-world comparative effectiveness analysis","volume":"24","author":"Khan","year":"2026","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"10.1016\/j.canlet.2026.218881_bib134","article-title":"Envafolimab combined with lenvatinib and gemcitabine plus cisplatin in advanced biliary tract cancer as first-line treatment: a multicenter, single-arm, open-label, phase II study (ENLIGHTEN study)","volume":"44","author":"Xu","year":"2026","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2026.218881_bib135","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s40425-019-0501-8","article-title":"Allogenic V\u03b39V\u03b42 T cell as new potential immunotherapy drug for solid tumor: a case study for cholangiocarcinoma","volume":"7","author":"Alnaggar","year":"2019","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.canlet.2026.218881_bib136","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13045-016-0378-7","article-title":"Cocktail treatment with EGFR-specific and CD133-specific chimeric antigen receptor-modified T cells in a patient with advanced cholangiocarcinoma","volume":"10","author":"Feng","year":"2017","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.canlet.2026.218881_bib137","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1142690","article-title":"Revisiting targeted therapy and immunotherapy for advanced cholangiocarcinoma","volume":"14","author":"Du","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2026.218881_bib138","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1200\/JCO.2011.40.5381","article-title":"Adjuvant therapy in the treatment of biliary tract cancer: a systematic review and meta-analysis","volume":"30","author":"Horgan","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2026.218881_bib139","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1245\/s10434-020-08355-3","article-title":"Phase 2 trial of adjuvant chemotherapy with S - 1 for node-positive biliary tract cancer (N-SOG 09)","volume":"27","author":"Seita","year":"2020","journal-title":"Ann. Surg Oncol."},{"key":"10.1016\/j.canlet.2026.218881_bib140","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1245\/s10434-022-12863-9","article-title":"Adjuvant chemoradiation in patients with lymph node-positive biliary tract cancers: secondary analysis of a single-arm clinical trial (SWOG 0809)","volume":"30","author":"Gholami","year":"2023","journal-title":"Ann. Surg Oncol."},{"key":"10.1016\/j.canlet.2026.218881_bib141","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s12916-024-03381-4","article-title":"Anti-PD-1 antibody in combination with radiotherapy as first-line therapy for unresectable intrahepatic cholangiocarcinoma","volume":"22","author":"Zhu","year":"2024","journal-title":"BMC Med."},{"key":"10.1016\/j.canlet.2026.218881_bib142","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1004135","article-title":"Integrated genomic characterization reveals novel, therapeutically relevant drug targets in FGFR and EGFR pathways in sporadic intrahepatic cholangiocarcinoma","volume":"10","author":"Borad","year":"2014","journal-title":"PLoS Genet."},{"key":"10.1016\/j.canlet.2026.218881_bib143","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S1470-2045(20)30109-1","article-title":"Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study","volume":"21","author":"Abou-Alfa","year":"2020","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.canlet.2026.218881_bib144","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1200\/JCO-26-00788","article-title":"Pemigatinib for unresectable or metastatic cholangiocarcinoma with fibroblast growth factor Receptor-2 rearrangement: results from the phase III FIGHT-302 trial","volume":"44","author":"Bekaii-Saab","year":"2026","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2026.218881_bib145","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1056\/NEJMoa2206834","article-title":"Futibatinib for FGFR2-Rearranged intrahepatic cholangiocarcinoma","volume":"388","author":"Goyal","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2026.218881_bib146","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.jhep.2017.03.026","article-title":"Emerging molecular therapeutic targets for cholangiocarcinoma","volume":"67","author":"Ilyas","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.canlet.2026.218881_bib147","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/S1470-2045(20)30157-1","article-title":"Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study","volume":"21","author":"Abou-Alfa","year":"2020","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.canlet.2026.218881_bib148","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/S1470-2045(21)00336-3","article-title":"Pertuzumab and trastuzumab for HER2-positive, metastatic biliary tract cancer (MyPathway): a multicentre, open-label, phase 2a, multiple basket study","volume":"22","author":"Javle","year":"2021","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.canlet.2026.218881_bib149","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1001\/jamaoncol.2025.4736","article-title":"Zanidatamab in HER2-Positive metastatic biliary tract cancer: final results from HERIZON-BTC-01","volume":"12","author":"Pant","year":"2026","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.canlet.2026.218881_bib150","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1200\/JCO.23.02010","article-title":"Trastuzumab deruxtecan in human epidermal growth factor receptor 2-Expressing biliary tract cancer (HERB; NCCH1805): a multicenter, single-arm, phase II trial","volume":"42","author":"Ohba","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2026.218881_bib151","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/S1470-2045(20)30321-1","article-title":"Dabrafenib plus trametinib in patients with BRAFV600E-mutated biliary tract cancer (ROAR): a phase 2, open-label, single-arm, multicentre basket trial","volume":"21","author":"Subbiah","year":"2020","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.canlet.2026.218881_bib152","doi-asserted-by":"crossref","DOI":"10.1200\/JCO-25-03128","article-title":"Efficacy and tolerability of zenocutuzumab in advanced NRG1 fusion-positive cholangiocarcinoma: results from the eNRGy phase II trial","author":"Cleary","year":"2026","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2026.218881_bib153","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2025.115338","article-title":"Efficacy and safety of larotrectinib in patients with TRK fusion gastrointestinal cancer","volume":"220","author":"Qi","year":"2025","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.canlet.2026.218881_bib154","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/S1470-2045(22)00541-1","article-title":"Tumour-agnostic efficacy and safety of selpercatinib in patients with RET fusion-positive solid tumours other than lung or thyroid tumours (LIBRETTO-001): a phase 1\/2, open-label, basket trial","volume":"23","author":"Subbiah","year":"2022","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.canlet.2026.218881_bib155","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1245\/s10434-018-6392-y","article-title":"Cytoplasmic Hu-Antigen R (HuR) expression is associated with poor survival in patients with surgically resected cholangiocarcinoma treated with adjuvant gemcitabine-based chemotherapy","volume":"25","author":"Toyota","year":"2018","journal-title":"Ann. Surg Oncol."},{"key":"10.1016\/j.canlet.2026.218881_bib156","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s10555-006-9026-y","article-title":"Lymphatic endothelial cells, tumor lymphangiogenesis and metastasis: new insights into intratumoral and peritumoral lymphatics","volume":"25","author":"Ji","year":"2006","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.canlet.2026.218881_bib157","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S1470-2045(11)70301-1","article-title":"Gemcitabine and oxaliplatin with or without erlotinib in advanced biliary-tract cancer: a multicentre, open-label, randomised, phase 3 study","volume":"13","author":"Lee","year":"2012","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.canlet.2026.218881_bib158","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S1470-2045(15)00139-4","article-title":"Cediranib or placebo in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancer (ABC-03): a randomised phase 2 trial","volume":"16","author":"Valle","year":"2015","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.canlet.2026.218881_bib159","doi-asserted-by":"crossref","first-page":"6290","DOI":"10.1038\/s41467-026-72541-2","article-title":"The multi-kinase inhibitor tinengotinib as monotherapy or combined with atezolizumab in advanced solid tumors: a phase Ib\/II trial","volume":"17","author":"Zhang","year":"2026","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2026.218881_bib160","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1158\/0008-5472.CAN-12-2130","article-title":"Therapeutic effects of deleting cancer-associated fibroblasts in cholangiocarcinoma","volume":"73","author":"Mertens","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2026.218881_bib161","article-title":"A phase 1b\/2 study of AK130 (TIGIT\/TGF-\u03b2 bispecific fusion protein) combined with ivonescimab in advanced biliary tract cancer (BTC)","volume":"44","author":"Zhao","year":"2026","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2026.218881_bib168","doi-asserted-by":"crossref","first-page":"7079","DOI":"10.3892\/mmr.2015.4239","article-title":"MicroRNA-101 inhibits the migration and invasion of intrahepatic cholangiocarcinoma cells via direct suppression of vascular endothelial growth factor-C","volume":"12","author":"Deng","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.canlet.2026.218881_bib173","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2019.152733","article-title":"Up-regulated LINC00261 predicts a poor prognosis and promotes a metastasis by EMT process in cholangiocarcinoma","volume":"216","author":"Gao","year":"2020","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.canlet.2026.218881_bib176","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/kjm2.12354","article-title":"LncRNA NEAT1 promotes cell proliferation, migration, and invasion via the miR-186-5p\/PTP4A1 axis in cholangiocarcinoma","volume":"37","author":"Li","year":"2021","journal-title":"Kaohsiung J. Med. Sci."},{"key":"10.1016\/j.canlet.2026.218881_bib177","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s13577-020-00448-1","article-title":"Yin Yang 1-induced LINC00667 up-regulates pyruvate dehydrogenase kinase 1 to promote proliferation, migration and invasion of cholangiocarcinoma cells by sponging miR-200c-3p","volume":"34","author":"Li","year":"2021","journal-title":"Hum. Cell"},{"key":"10.1016\/j.canlet.2026.218881_bib178","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s00535-023-02015-5","article-title":"VIRMA facilitates intrahepatic cholangiocarcinoma progression through epigenetic augmentation of TMED2 and PARD3B mRNA stabilization","volume":"58","author":"Xu","year":"2023","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.canlet.2026.218881_bib180","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2022.2156255","article-title":"Intratumor microbiome features reveal antitumor potentials of intrahepatic cholangiocarcinoma","volume":"15","author":"Chai","year":"2023","journal-title":"Gut Microbes"},{"key":"10.1016\/j.canlet.2026.218881_bib181","article-title":"FomA-Containing outer membrane vesicles of Fusobacterium nucleatum facilitate bladder cancer lymphatic metastasis via IL-6-Dependent M2b macrophage polarization","volume":"13","author":"Shangguan","year":"2026","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.canlet.2026.218881_bib182","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1016\/j.cell.2024.03.021","article-title":"A pan-cancer analysis of the microbiome in metastatic cancer","volume":"187","author":"Battaglia","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2026.218881_bib183","doi-asserted-by":"crossref","first-page":"685","DOI":"10.3350\/cmh.2024.1039","article-title":"Unveiling the intratumor microbiome in liver cancer: current insights and prospective applications","volume":"31","author":"Ke","year":"2025","journal-title":"Clin. Mol. Hepatol."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526006452?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526006452?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T06:21:16Z","timestamp":1792822876000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383526006452"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":198,"alternative-id":["S0304383526006452"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218881","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Deciphering the metastatic nexus: Molecular drivers and therapeutic frontiers in cholangiocarcinoma lymph node dissemination","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218881","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"218881"}}